Skip to content

Epidural Analgesia (EDA) Versus Patient Controlled Analgesia (PCA) in Laparoscopic Colon Surgery

Epidural Analgesia (EDA) Versus Patient Controlled Analgesia (PCA) in Laparoscopic Colon Surgery: A Monocentric Controlled Non-blinded Randomized Superiority Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00508300
Acronym
EVA
Enrollment
128
Registered
2007-07-27
Start date
2010-01-31
Completion date
2013-10-31
Last updated
2020-08-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laparoscopic Colectomy

Keywords

laparoscopic, colectomy, Fast Track, epidural

Brief summary

The purpose of this study is to determine whether a epidural analgesia versus patient controlled analgesia reduces the medical recovery in patients undergoing elective laparoscopic colon surgery.

Detailed description

Allocation by individual random number generated by a computer program to either EDA or PCA for 48h after laparoscopic colonic surgery. Short, both groups are treated according to a recent Fast track protocol. Group A will preoperatively receive a mid thoracic EDA (th 8-9; naropine 0,1%) while group B will receive a PCA (morphine) postoperatively. Both EDA and PCA are removed the afternoon at day 2. Patients with a non-functioning EDA within the first 24h will be crossed over to the PCA group.

Interventions

PROCEDUREEpidural analgesia

Thoracic epidural analgesia until day 2

PROCEDUREPatient controlled analgesia

Patient controlled analgesia (morphine-based)

Sponsors

University of Lausanne Hospitals
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All patients admitted for elective laparoscopic colonic surgery

Exclusion criteria

* Age \< 18y * No informed consent * Emergency situation * Contraindication for EDA (according to local Anesthesia guidelines)

Design outcomes

Primary

MeasureTime frameDescription
Medical Recovery (Defined as Pain Sufficient Controlled by Oral Analgesia, Fully Mobile Patients or at Least as Mobile as at Admission and Tolerance of the Patient of Oral Food Intake (More Than 2/3 of Daily Meal))30 daysMedical recovery was chosen as primary end point and was defined as the fulfillment of all the 3 following criteria: (1) sufficient pain control by oral analgesics, (2) fully mobilized or at least comparable with preoperative status, and (3) tolerance of oral food that was defined as two thirds or more of normal meal (hospital portion).23 Medical recovery was considered as more specific outcome parameter than hospital stay because social and logistic factors were not interfering.24,25

Secondary

MeasureTime frame
Complication Rate, Peridural Analgesia Failure Rate, Patient Comfort30 days

Countries

Switzerland

Participant flow

Participants by arm

ArmCount
Epidural
epidural catheter was inserted at thoracic level (Th8-Th10) before induction of anesthesia. A bolus of 5 mL of bupivacaine 0.5% was started as soon as the epidural catheter was in place, and a continuous perfusion of bupivacaine 0.5% at 5 mL/hr was initiated until the end of surgical procedure.
65
Patient-controlled Analgesia
In the PCA group, intravenous PCA was inserted with 1 mg/h. A bolus of 1 mL was allowed at every 5 minutes up to a maximal dose of 40 mg/4h.
57
Total122

Baseline characteristics

CharacteristicPatient-controlled AnalgesiaTotalEpidural
Age, Continuous61.2 years
STANDARD_DEVIATION 17.8
62.5 years
STANDARD_DEVIATION 16.3
63.1 years
STANDARD_DEVIATION 15.1
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
Switzerland
57 participants122 participants65 participants
Sex: Female, Male
Female
23 Participants51 Participants28 Participants
Sex: Female, Male
Male
34 Participants71 Participants37 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
2 / 650 / 57
other
Total, other adverse events
0 / 650 / 57
serious
Total, serious adverse events
13 / 655 / 57

Outcome results

Primary

Medical Recovery (Defined as Pain Sufficient Controlled by Oral Analgesia, Fully Mobile Patients or at Least as Mobile as at Admission and Tolerance of the Patient of Oral Food Intake (More Than 2/3 of Daily Meal))

Medical recovery was chosen as primary end point and was defined as the fulfillment of all the 3 following criteria: (1) sufficient pain control by oral analgesics, (2) fully mobilized or at least comparable with preoperative status, and (3) tolerance of oral food that was defined as two thirds or more of normal meal (hospital portion).23 Medical recovery was considered as more specific outcome parameter than hospital stay because social and logistic factors were not interfering.24,25

Time frame: 30 days

Population: accorindg to intention-to-treat principle

ArmMeasureValue (MEDIAN)
EpiduralMedical Recovery (Defined as Pain Sufficient Controlled by Oral Analgesia, Fully Mobile Patients or at Least as Mobile as at Admission and Tolerance of the Patient of Oral Food Intake (More Than 2/3 of Daily Meal))5 days
Patient-controlled AnalgesiaMedical Recovery (Defined as Pain Sufficient Controlled by Oral Analgesia, Fully Mobile Patients or at Least as Mobile as at Admission and Tolerance of the Patient of Oral Food Intake (More Than 2/3 of Daily Meal))4 days
Secondary

Complication Rate, Peridural Analgesia Failure Rate, Patient Comfort

Time frame: 30 days

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026